Lymph Node Assessment Using Simultaneous 18F-FDG-PET and MRI

Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer

NCT00416455 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Head-to-head Comparison Between [18F]-FDG PET/CT and PET/MRI in Lymphomas

NCT05390632 ·Status: UNKNOWN

Assessment of Treatment Response of Nasopharyngeal Cancer Using Simultaneous 18F-FDG-PET and MRI

NCT03656250 ·Status: COMPLETED

Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.

NCT00782691 ·Status: UNKNOWN

Detection and Characterization of Residual Masses in Lymphomas

NCT02300402 ·Status: COMPLETED

Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions

NCT01880762 ·Status: COMPLETED

Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer

NCT07285564 ·Status: RECRUITING ·Phase: NA

PET and MRI in Prognosis Prediction of NPC

NCT03429868 ·Status: COMPLETED ·Phase: NA

Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's Lymphoma

NCT00188929 ·Status: COMPLETED ·Phase: PHASE2

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

NCT00757549 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation

NCT00313027 ·Status: COMPLETED ·Phase: NA

Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma

NCT00110006 ·Status: WITHDRAWN ·Phase: NA

PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer

NCT01737619 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Diffusion MRI for Head and Neck Cancer

NCT04251481 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma

NCT00775268 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Combined FDG PET/CT Imaging in Response Evaluation After Radiochemotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

NCT01179360 ·Status: COMPLETED

Validation of USPIO-enhanced MRI for Detection of Lymph Node Metastases in Head and Neck Carcinoma

NCT03817307 ·Status: UNKNOWN ·Phase: NA

Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma

NCT06795113 ·Status: RECRUITING

Wholebody MRI In Lung Cancer StagiNg

NCT02716051 ·Status: COMPLETED ·Phase: NA

PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning

NCT03286972 ·Status: TERMINATED

MRI and PET-CT for Radiotherapy Planning for Head and Neck Cancer

NCT02273778 ·Status: COMPLETED ·Phase: NA

Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma

NCT00072488 ·Status: UNKNOWN ·Phase: NA

Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)

NCT01004718 ·Status: COMPLETED ·Phase: NA

Molecular and Whole-body MR Imaging in Lymphomas

NCT02389101 ·Status: COMPLETED ·Phase: NA

Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma

NCT03051542 ·Status: UNKNOWN ·Phase: NA